Tian Songhai, Liu Yang, Wu Hao, Liu Hao, Zeng Ji, Choi Mei Yuk, Chen Hong, Gerhard Ralf, Dong Min
Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Surgery and Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.
Department of Urology, Boston Children's Hospital, Boston, MA 02115, USA; Department of Surgery and Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA; Department of Nephrology, The First Hospital of Jilin University, Changchun 130012, China.
Cell Host Microbe. 2020 May 13;27(5):782-792.e7. doi: 10.1016/j.chom.2020.03.007. Epub 2020 Apr 16.
The exotoxin TcsL is a major virulence factor in Paeniclostridium (Clostridium) sordellii and responsible for the high lethality rate associated with P. sordellii infection. Here, we present a genome-wide CRISPR-Cas9-mediated screen using a human lung carcinoma cell line and identify semaphorin (SEMA) 6A and 6B as receptors for TcsL. Disrupting SEMA6A/6B expression in several distinct human cell lines and primary human endothelial cells results in reduced TcsL sensitivity, while SEMA6A/6B over-expression increases their sensitivity. TcsL recognizes the extracellular domain (ECD) of SEMA6A/6B via a region homologous to the receptor-binding site in Clostridioides difficile toxin B (TcdB), which binds the human receptor Frizzled. Exchanging the receptor-binding interfaces between TcsL and TcdB switches their receptor-binding specificity. Finally, administration of SEMA6A-ECD proteins protects human cells from TcsL toxicity and reduces TcsL-induced damage to lung tissues and the lethality rate in mice. These findings establish SEMA6A and 6B as pathophysiologically relevant receptors for TcsL.
外毒素TcsL是索氏类芽孢杆菌(梭菌属)的一种主要毒力因子,与索氏类芽孢杆菌感染相关的高致死率有关。在此,我们使用人肺癌细胞系进行了全基因组CRISPR-Cas9介导的筛选,并确定信号素(SEMA)6A和6B为TcsL的受体。在几种不同的人类细胞系和原代人内皮细胞中破坏SEMA6A/6B的表达会导致TcsL敏感性降低,而SEMA6A/6B的过表达会增加它们的敏感性。TcsL通过与艰难梭菌毒素B(TcdB)中与受体结合位点同源的区域识别SEMA6A/6B的细胞外结构域(ECD),TcdB可结合人类受体卷曲蛋白。交换TcsL和TcdB之间的受体结合界面会改变它们的受体结合特异性。最后,给予SEMA6A-ECD蛋白可保护人类细胞免受TcsL毒性,并减少TcsL对肺组织的损伤以及小鼠的致死率。这些发现确立了SEMA6A和6B作为TcsL在病理生理学上相关的受体。